Literature DB >> 27987832

Dual pH/redox responsive and CD44 receptor targeting hybrid nano-chrysalis based on new oligosaccharides of hyaluronan conjugates.

Daquan Chen1, Xue Dong2, Mengjiao Qi2, Xiaoyan Song2, Jingfang Sun2.   

Abstract

A smart hybrid microenvironment-mediated dual pH/redox-responsive polymeric nanoparticles combined with inorganic calcium phosphate (CaP) was fabricated, which we term as armored nano-chrysalis inspired by butterfly pupa. The nano-chrysalis has an inner core composed of specially designed oligosaccharides of hyaluronan (oHA) targeting CD44 receptor. The inner core has two functions, i.e., the dual pH/redox responsive polymeric conjugate and the fluorescent curcumin-prodrug function. The prepared nano-chrysalis possessed a smaller size (102.5±4.6nm) than the unarmored nano-chrysalis (122.5±6.6nm). Interestingly, while the nano-chrysalis were stable under pH 7.4, when incubated under the tumor acidic conditions (pH 6.5) the outer CaP armor would dissolve in a pH-dependent, sustained manner. Moreover, nano-chrysalis was demonstrated to present the most effective antitumor efficacy than other formulations. This study provides a promising smart nano-carrier platform to enhance the stability, decrease the side effects, and improve the therapeutic efficacy of anticancer drugs.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bioinspired prodrug; Dual pH/redox responsive; Multifunctional nanoparticles; Oligosaccharides of hyaluronan; Smart drug delivery

Mesh:

Substances:

Year:  2016        PMID: 27987832     DOI: 10.1016/j.carbpol.2016.10.089

Source DB:  PubMed          Journal:  Carbohydr Polym        ISSN: 0144-8617            Impact factor:   9.381


  7 in total

Review 1.  Targeting Strategies for the Combination Treatment of Cancer Using Drug Delivery Systems.

Authors:  Janel Kydd; Rahul Jadia; Praveena Velpurisiva; Aniket Gad; Shailee Paliwal; Prakash Rai
Journal:  Pharmaceutics       Date:  2017-10-14       Impact factor: 6.321

2.  Development of dual-targeted nano-dandelion based on an oligomeric hyaluronic acid polymer targeting tumor-associated macrophages for combination therapy of non-small cell lung cancer.

Authors:  Bingjie Wang; Wei Zhang; Xiudi Zhou; Mengna Liu; Xiaoya Hou; Ziting Cheng; Daquan Chen
Journal:  Drug Deliv       Date:  2019-12       Impact factor: 6.419

Review 3.  Smart Responsive Nanoformulation for Targeted Delivery of Active Compounds From Traditional Chinese Medicine.

Authors:  Xuejun Jiang; Mei Lin; Jianwen Huang; Mulan Mo; Houhe Liu; Yuan Jiang; Xiaowen Cai; Wingnang Leung; Chuanshan Xu
Journal:  Front Chem       Date:  2020-12-10       Impact factor: 5.221

4.  Novel hyaluronic acid oligosaccharide-loaded and CD44v6-targeting oxaliplatin nanoparticles for the treatment of colorectal cancer.

Authors:  Wenlong Du; Xiaoping Yang; Shenfu He; Jia Wang; Yuanxian Guo; Bangguo Kou; Yongjie Jiang; Pan Bian; Bingtai Li; Lanning Yin
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

Review 5.  Nanoparticulation of Prodrug into Medicines for Cancer Therapy.

Authors:  Yuezhou Zhang; Huaguang Cui; Ruiqi Zhang; Hongbo Zhang; Wei Huang
Journal:  Adv Sci (Weinh)       Date:  2021-07-29       Impact factor: 16.806

6.  Novel Dual Mitochondrial and CD44 Receptor Targeting Nanoparticles for Redox Stimuli-Triggered Release.

Authors:  Kaili Wang; Mengjiao Qi; Chunjing Guo; Yueming Yu; Bingjie Wang; Lei Fang; Mengna Liu; Zhen Wang; Xinxin Fan; Daquan Chen
Journal:  Nanoscale Res Lett       Date:  2018-02-02       Impact factor: 4.703

7.  Novel nano-pomegranates based on astragalus polysaccharides for targeting ERα-positive breast cancer and multidrug resistance.

Authors:  Bingjie Wang; Chunjing Guo; Yanhui Liu; Guangting Han; Yi Li; Yanchun Zhang; Haiyu Xu; Daquan Chen
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.